Suppr超能文献

对新进入血液透析和腹膜透析患者的倾向性匹配死亡率比较。

Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients.

机构信息

Chronic Disease Research Group, Minneapolis, MN 55404, USA.

出版信息

J Am Soc Nephrol. 2010 Mar;21(3):499-506. doi: 10.1681/ASN.2009060635. Epub 2010 Feb 4.

Abstract

Contemporary comparisons of mortality in matched hemodialysis and peritoneal dialysis patients are lacking. We aimed to compare survival of incident hemodialysis and peritoneal dialysis patients by intention-to-treat analysis in a matched-pair cohort and in subsets defined by age, cardiovascular disease, and diabetes. We matched 6337 patient pairs from a retrospective cohort of 98,875 adults who initiated dialysis in 2003 in the United States. In the primary intention-to-treat analysis of survival from day 0, cumulative survival was higher for peritoneal dialysis patients than for hemodialysis patients (hazard ratio 0.92; 95% CI 0.86 to 1.00, P = 0.04). Cumulative survival probabilities for peritoneal dialysis versus hemodialysis were 85.8% versus 80.7% (P < 0.01), 71.1% versus 68.0% (P < 0.01), 58.1% versus 56.7% (P = 0.25), and 48.4% versus 47.3% (P = 0.50) at 12, 24, 36, and 48 months, respectively. Peritoneal dialysis was associated with improved survival compared with hemodialysis among subgroups with age <65 years, no cardiovascular disease, and no diabetes. In a sensitivity analysis of survival from 90 days after initiation, we did not detect a difference in survival between modalities overall (hazard ratio 1.05; 95% CI 0.96 to 1.16), but hemodialysis was associated with improved survival among subgroups with cardiovascular disease and diabetes. In conclusion, despite hazard ratio heterogeneity across patient subgroups and nonconstant hazard ratios during the follow-up period, the overall intention-to-treat mortality risk after dialysis initiation was 8% lower for peritoneal dialysis than for matched hemodialysis patients. These data suggest that increased use of peritoneal dialysis may benefit incident ESRD patients.

摘要

目前缺乏血液透析和腹膜透析患者死亡率的当代比较。我们旨在通过匹配对队列和按年龄、心血管疾病和糖尿病定义的亚组进行意向治疗分析,比较新开始血液透析和腹膜透析患者的生存情况。我们匹配了 2003 年在美国开始透析的 98875 名成年人回顾性队列中的 6337 对患者。在生存意向治疗分析的主要分析中,从第 0 天开始,腹膜透析患者的累积生存率高于血液透析患者(风险比 0.92;95%置信区间 0.86 至 1.00,P = 0.04)。腹膜透析与血液透析的累积生存率分别为 85.8%和 80.7%(P < 0.01)、71.1%和 68.0%(P < 0.01)、58.1%和 56.7%(P = 0.25)和 48.4%和 47.3%(P = 0.50),分别在 12、24、36 和 48 个月时。在年龄<65 岁、无心血管疾病和无糖尿病的亚组中,腹膜透析与血液透析相比,生存情况得到改善。在起始后 90 天生存的敏感性分析中,我们并未发现总体上两种方式之间的生存差异(风险比 1.05;95%置信区间 0.96 至 1.16),但在有心血管疾病和糖尿病的亚组中,血液透析与生存情况改善相关。总之,尽管在患者亚组中存在风险比异质性且在随访期间风险比不恒定,但与匹配的血液透析患者相比,腹膜透析患者在透析开始后的总体意向治疗死亡率低 8%。这些数据表明,增加腹膜透析的使用可能会使新发生的终末期肾病患者受益。

相似文献

引用本文的文献

5
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
6
Peritoneal Dialysis Technique Survival: A Cohort Study.腹膜透析技术生存率:一项队列研究。
Am J Kidney Dis. 2024 Sep;84(3):298-305.e1. doi: 10.1053/j.ajkd.2024.03.012. Epub 2024 Apr 17.
10
An update on absolute and relative indications for dialysis treatment modalities.透析治疗方式的绝对和相对指征的最新情况。
Clin Kidney J. 2023 Sep 13;16(Suppl 1):i39-i47. doi: 10.1093/ckj/sfad062. eCollection 2023 Sep.

本文引用的文献

2
Relationship between dialysis modality and mortality.透析方式与死亡率之间的关系。
J Am Soc Nephrol. 2009 Jan;20(1):155-63. doi: 10.1681/ASN.2007111188. Epub 2008 Dec 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验